JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2017 • Pharmstandard International S.A. • Pharmaceutical preparations
We, the undersigned, hereby express our agreement that the attached Schedule 13G is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2018 • Pharmstandard International S.A. • Biological products, (no disgnostic substances)
We, the undersigned, hereby express our agreement that the attached Schedule 13G is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
JOINT FILING AGREEMENTJoint Filing Agreement • November 15th, 2018 • Pharmstandard International S.A. • Biological products, (no disgnostic substances)
We, the undersigned, hereby express our agreement that the attached Schedule 13G is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
SCHEDULE 13GJoint Filing Agreement • February 12th, 2015 • Pharmstandard International S.A. • Pharmaceutical preparations
SALE AND PURCHASE AGREEMENTSale and Purchase Agreement • May 27th, 2016 • Pharmstandard International S.A. • Pharmaceutical preparations • New York
This SALE AND PURCHASE AGREEMENT (this “Agreement”), dated as of May 19, 2016 (the “Effective Date”), by and between Pharmstandard International S.A., a Luxembourg public limited liability company (the “Seller”), and Ervington Investments Limited, a Cyprus limited liability company (the “Purchaser”). The Seller and the Purchaser are referred to herein individually as a “Party” and together as the “Parties.”
SCHEDULE 13GJoint Filing Agreement • February 12th, 2015 • Pharmstandard International S.A. • Biological products, (no disgnostic substances)
